Asciminib for the Treatment of Patients With Chronic Myeloid Leukemia

H&O  What is the current treatment approach for patients with chronic myeloid leukemia (CML)? JC  Patients with CML begin treatment with a tyrosine kinase inhibitor (TKI) […]

Treatment-Free Remission in Chronic Myeloid Leukemia

  Abstract:  Tyrosine kinase inhibitors (TKIs) represent a major breakthrough in the treatment of chronic myeloid leukemia (CML). Thanks to these agents, CML has been transformed […]

What Should Frontline Treatment Be in Chronic Myeloid Leukemia?

The US Food and Drug Administration has approved 3 tyrosine kinase inhibitors (TKIs) for use as frontline treatment in chronic myeloid leukemia (CML): imatinib, dasatinib (Sprycel, […]